British journal of cancer

Keyphrases

Publications

volume 131, number 4, 2024

Christopher R Cardwell, Tom A Ranger, Alexander M Labeit, Carol A C Coupland, Blánaid Hicks, Carmel Hughes, Úna McMenamin, Xue W Mei, Peter Murchie, Julia Hippisley-Cox
Hormone replacement therapy and cancer mortality in women with 17 site-specific cancers: a cohort study using linked medical records. British journal of cancer 131 (4) (2024)
S Rae, S Shaya, E Taylor, J Hoben, D Oluwashegun, H Lowe, N Haris, S Bashir, C Oing, M G Krebs, F C Thistlethwaite, L Carter, Natalie Cook, A Greystoke, D M Graham, R Plummer
Social determinants of health inequalities in early phase clinical trials in Northern England. British journal of cancer 131 (4) (2024)
Wenjia Zuo, Zhonghua Wang, Jun Qian, Xiaopeng Ma, Zhaofeng Niu, Jianghua Ou, Qinguo Mo, Jing Sun, Xinzheng Li, Qitang Wang, Yongzhong Yao, Guohua Yu, Hongsheng Li, Dedian Chen, Hao Zhang, Cuizhi Geng, Guangdong Qiao, Mengmeng Zhao, Baihui Zhang, Xiaoyan Kang, Jin Zhang, Zhimin Shao
QL1209 (pertuzumab biosimilar) versus reference pertuzumab plus trastuzumab and docetaxel in neoadjuvant treatment for HER2-positive, ER/PR-negative, early or locally advanced breast cancer: A multicenter, randomized, double-blinded, parallel-controlled, phase III equivalence trial. British journal of cancer 131 (4) (2024)
Jilong Yuan, Ming Xiao, Qu Zheng
Comment on: "A nationwide study of breast reconstruction after mastectomy in patients with breast cancer receiving postmastectomy radiotherapy: comparison of complications according to radiotherapy fractionation and reconstruction procedures". British journal of cancer 131 (4) (2024)
Sen Wang, Kexin Wang, Dong Yue, Xiaxia Yang, Xiaozao Pan, Feifei Kong, Rou Zhao, Qingli Bie, Dongxing Tian, Shuqing Zhu, Baoyu He, Zhang Bin
MT1G induces lipid droplet accumulation through modulation of H3K14 trimethylation accelerating clear cell renal cell carcinoma progression. British journal of cancer 131 (4) (2024)
Nouredin Messaoudi, Aude Vanlander, Andrew A Gumbs
Optimizing adjuvant treatment strategies for non-pancreatic periampullary cancers. British journal of cancer 131 (4) (2024)
Anders Bojesson, Eva Brun, Jakob Eberhard, Mikael Segerlantz
Quality of life for patients with advanced gastrointestinal cancer randomised to early specialised home-based palliative care: the ALLAN trial. British journal of cancer 131 (4) (2024)
Hui Xu, Michael Bretthauer, Fang Fang, Weimin Ye, Li Yin, Hans-Olov Adami
Dramatic improvements in outcome following pancreatoduodenectomy for pancreatic and periampullary cancers. British journal of cancer 131 (4) (2024)
François Poumeaud, M Morisseau, Luc Cabel, A Gonçalves, C Rivier, O Trédan, E Volant, Jean-Sébastien Frenel, S Ladoire, William Jacot, M Jamelot, H Foka Tichoue, Anne Patsouris, Luis Teixeira, F-C Bidard, D Loirat, M Brunet, C Levy, Caroline Bailleux, B Cabarrou, A Deleuze, L Uwer, E Deluche, T Grellety, C Franchet, F Fiteni, H Bischoff, R Vion, M Pagliuca, B Verret, S Bécourt, T Reverdy, A de Nonneville, F Dalenc
Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer. British journal of cancer 131 (4) (2024)
Christopher R Cardwell, Tom A Ranger, Alexander M Labeit, Carol A C Coupland, Blánaid Hicks, Carmel Hughes, Úna McMenamin, Xue W Mei, Peter Murchie, Julia Hippisley-Cox
Hormone replacement therapy and cancer mortality in women with 17 site-specific cancers: a cohort study using linked medical records. British journal of cancer 131 (4) (2024)
Teng Zhu, Yu-Hong Huang, Wei Li, Can-Gui Wu, Yi-Min Zhang, Xing-Xing Zheng, Ting-Feng Zhang, Ying-Yi Lin, Zai-Yi Liu, Guo-Lin Ye, Ying Lin, Zhi-Yong Wu, Kun Wang
A non-invasive artificial intelligence model for identifying axillary pathological complete response to neoadjuvant chemotherapy in breast cancer: a secondary analysis to multicenter clinical trial. British journal of cancer 131 (4) (2024)
François Poumeaud, M Morisseau, Luc Cabel, A Gonçalves, C Rivier, O Trédan, E Volant, Jean-Sébastien Frenel, S Ladoire, William Jacot, M Jamelot, H Foka Tichoue, Anne Patsouris, Luis Teixeira, F-C Bidard, D Loirat, M Brunet, C Levy, Caroline Bailleux, B Cabarrou, A Deleuze, L Uwer, E Deluche, T Grellety, C Franchet, F Fiteni, H Bischoff, R Vion, M Pagliuca, B Verret, S Bécourt, T Reverdy, A de Nonneville, F Dalenc
Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer. British journal of cancer 131 (4) (2024)
Hege Elvebakken, Andreas Venizelos, Aurel Perren, Anne Couvelard, Inger Marie B Lothe, Geir O Hjortland, Tor-Åge Myklebust, Johanna Svensson, Herish Garresori, Christian Kersten, Eva Hofsli, Sönke Detlefsen, Lene W Vestermark, Stian Knappskog, Halfdan Sorbye
Treatment outcome according to genetic tumour alterations and clinical characteristics in digestive high-grade neuroendocrine neoplasms. British journal of cancer 131 (4) (2024)
Ruixi Wang, Shiliang Liu, Baoqing Chen, Qiaoqiao Li, Xingyuan Cheng, Yujia Zhu, Li Zhang, Yonghong Hu, Mengzhong Liu, Yingying Hu, Mian Xi
Prognostic significance of PET/CT and its association with immuno-genomic profiling in oesophageal squamous cell carcinoma treated with immunotherapy plus chemoradiotherapy: results from a phase II study. British journal of cancer 131 (4) (2024)
Lynne Lohfeld, Meenakshi Sharma, Damien Bennett, Anna Gavin, Sinéad T Hawkins, Gareth Irwin, Helen Mitchell, Siobhan O'Neill, Charlene M McShane
Impact of the COVID-19 pandemic on breast cancer patient pathways and outcomes in the United Kingdom and the Republic of Ireland - a scoping review. British journal of cancer 131 (4) (2024)
Jenna H Rannikko, Maija Hollmén
Clinical landscape of macrophage-reprogramming cancer immunotherapies. British journal of cancer 131 (4) (2024)
Alexandra Wachtmeister, Giorgio Tettamanti, Ida Nordgren, Christina Norrby, Tobias Laurell, Yunxia Lu, Anna Skarin Nordenvall, Ann Nordgren
Cancer risk in individuals with polydactyly: a Swedish population-based cohort study. British journal of cancer 131 (4) (2024)
Hui Xu, Michael Bretthauer, Fang Fang, Weimin Ye, Li Yin, Hans-Olov Adami
Dramatic improvements in outcome following pancreatoduodenectomy for pancreatic and periampullary cancers. British journal of cancer 131 (4) (2024)
Ruixi Wang, Shiliang Liu, Baoqing Chen, Qiaoqiao Li, Xingyuan Cheng, Yujia Zhu, Li Zhang, Yonghong Hu, Mengzhong Liu, Yingying Hu, Mian Xi
Prognostic significance of PET/CT and its association with immuno-genomic profiling in oesophageal squamous cell carcinoma treated with immunotherapy plus chemoradiotherapy: results from a phase II study. British journal of cancer 131 (4) (2024)
Caroline Boman, Xingrong Liu, Louise Eriksson Bergman, Wenwen Sun, Christian Tranchell, Maria Angeliki Toli, Balazs Acs, Jonas Bergh, Theodoros Foukakis, Alexios Matikas
A population-based study on trajectories of HER2 status during neoadjuvant chemotherapy for early breast cancer and metastatic progression. British journal of cancer 131 (4) (2024)
Teng Zhu, Yu-Hong Huang, Wei Li, Can-Gui Wu, Yi-Min Zhang, Xing-Xing Zheng, Ting-Feng Zhang, Ying-Yi Lin, Zai-Yi Liu, Guo-Lin Ye, Ying Lin, Zhi-Yong Wu, Kun Wang
A non-invasive artificial intelligence model for identifying axillary pathological complete response to neoadjuvant chemotherapy in breast cancer: a secondary analysis to multicenter clinical trial. British journal of cancer 131 (4) (2024)
Till Seiboldt, Constantia Zeiser, Duy Nguyen, Simay Celikyürekli, Sonja Herter, Sara Najafi, Alexandra Stroh-Dege, Chris Meulenbroeks, Norman Mack, Rabia Salem-Altintas, Frank Westermann, Matthias Schlesner, Till Milde, Marcel Kool, Tim Holland-Letz, Meike Vogler, Heike Peterziel, Olaf Witt, Ina Oehme
Synergy of retinoic acid and BH3 mimetics in MYC(N)-driven embryonal nervous system tumours. British journal of cancer 131 (4) (2024)
Sen Wang, Kexin Wang, Dong Yue, Xiaxia Yang, Xiaozao Pan, Feifei Kong, Rou Zhao, Qingli Bie, Dongxing Tian, Shuqing Zhu, Baoyu He, Zhang Bin
MT1G induces lipid droplet accumulation through modulation of H3K14 trimethylation accelerating clear cell renal cell carcinoma progression. British journal of cancer 131 (4) (2024)
Hege Elvebakken, Andreas Venizelos, Aurel Perren, Anne Couvelard, Inger Marie B Lothe, Geir O Hjortland, Tor-Åge Myklebust, Johanna Svensson, Herish Garresori, Christian Kersten, Eva Hofsli, Sönke Detlefsen, Lene W Vestermark, Stian Knappskog, Halfdan Sorbye
Treatment outcome according to genetic tumour alterations and clinical characteristics in digestive high-grade neuroendocrine neoplasms. British journal of cancer 131 (4) (2024)
Wenjia Zuo, Zhonghua Wang, Jun Qian, Xiaopeng Ma, Zhaofeng Niu, Jianghua Ou, Qinguo Mo, Jing Sun, Xinzheng Li, Qitang Wang, Yongzhong Yao, Guohua Yu, Hongsheng Li, Dedian Chen, Hao Zhang, Cuizhi Geng, Guangdong Qiao, Mengmeng Zhao, Baihui Zhang, Xiaoyan Kang, Jin Zhang, Zhimin Shao
QL1209 (pertuzumab biosimilar) versus reference pertuzumab plus trastuzumab and docetaxel in neoadjuvant treatment for HER2-positive, ER/PR-negative, early or locally advanced breast cancer: A multicenter, randomized, double-blinded, parallel-controlled, phase III equivalence trial. British journal of cancer 131 (4) (2024)
Lynne Lohfeld, Meenakshi Sharma, Damien Bennett, Anna Gavin, Sinéad T Hawkins, Gareth Irwin, Helen Mitchell, Siobhan O'Neill, Charlene M McShane
Impact of the COVID-19 pandemic on breast cancer patient pathways and outcomes in the United Kingdom and the Republic of Ireland - a scoping review. British journal of cancer 131 (4) (2024)
Caroline Boman, Xingrong Liu, Louise Eriksson Bergman, Wenwen Sun, Christian Tranchell, Maria Angeliki Toli, Balazs Acs, Jonas Bergh, Theodoros Foukakis, Alexios Matikas
A population-based study on trajectories of HER2 status during neoadjuvant chemotherapy for early breast cancer and metastatic progression. British journal of cancer 131 (4) (2024)
Yingxi Zhao, Yonghao Zheng, Jinjiang Fu, Jiayu Zhang, Hui Shao, Shougeng Liu, Jiacheng Lai, Xue Zhou, Ruijuan Liang, Lina Jia, Wei Cui, Jingyu Yang, Chunfu Wu, Lihui Wang
KDM1A, a potent and selective target, for the treatment of DNMT3A-deficient non-small cell lung cancer. British journal of cancer 131 (4) (2024)
S Rae, S Shaya, E Taylor, J Hoben, D Oluwashegun, H Lowe, N Haris, S Bashir, C Oing, M G Krebs, F C Thistlethwaite, L Carter, Natalie Cook, A Greystoke, D M Graham, R Plummer
Social determinants of health inequalities in early phase clinical trials in Northern England. British journal of cancer 131 (4) (2024)
Jenna H Rannikko, Maija Hollmén
Clinical landscape of macrophage-reprogramming cancer immunotherapies. British journal of cancer 131 (4) (2024)
Jilong Yuan, Ming Xiao, Qu Zheng
Comment on: "A nationwide study of breast reconstruction after mastectomy in patients with breast cancer receiving postmastectomy radiotherapy: comparison of complications according to radiotherapy fractionation and reconstruction procedures". British journal of cancer 131 (4) (2024)
Caroline Boman, Xingrong Liu, Louise Eriksson Bergman, Wenwen Sun, Christian Tranchell, Maria Angeliki Toli, Balazs Acs, Jonas Bergh, Theodoros Foukakis, Alexios Matikas
A population-based study on trajectories of HER2 status during neoadjuvant chemotherapy for early breast cancer and metastatic progression. British journal of cancer 131 (4) (2024)
Yingxi Zhao, Yonghao Zheng, Jinjiang Fu, Jiayu Zhang, Hui Shao, Shougeng Liu, Jiacheng Lai, Xue Zhou, Ruijuan Liang, Lina Jia, Wei Cui, Jingyu Yang, Chunfu Wu, Lihui Wang
KDM1A, a potent and selective target, for the treatment of DNMT3A-deficient non-small cell lung cancer. British journal of cancer 131 (4) (2024)

volume 131, number 5, 2024

Maud B A van der Kleij, Niels A D Guchelaar, Marinda Meertens, Kim Westerdijk, Eline L Giraud, Roos F Bleckman, Stefanie L Groenland, Ruben A G van Eerden, Alex L T Imholz, Annelie J E Vulink, Hans-Martin Otten, Helle-Brit Fiebrich-Westra, Floor J E Lubberman, Ingrid M E Desar, Dirk Jan A R Moes, Daan J Touw, Stijn L W Koolen, Hans Gelderblom, Anna K L Reyners, Nielka P van Erp, Ron H J Mathijssen, Alwin D R Huitema, null null, Neeltje Steeghs
Reasons for non-feasibility of therapeutic drug monitoring of oral targeted therapies in oncology - an analysis of the closed cohorts of a multicentre prospective study. British journal of cancer 131 (5) (2024)
Yoshihiro Hara, Yoshifumi Baba, Eri Oda, Kazuto Harada, Kohei Yamashita, Tasuku Toihata, Keisuke Kosumi, Masaaki Iwatsuki, Yuji Miyamoto, Hiroyasu Tsutsuki, Qiong Gan, Rebecca E Waters, Yoshihiro Komohara, Tomohiro Sawa, Jaffer A Ajani, Hideo Baba
Presence of Fusobacterium nucleatum in relation to patient survival and an acidic environment in oesophagogastric junction and gastric cancers. British journal of cancer 131 (5) (2024)
N Johnson, J Bentley, L-Z Wang, D R Newell, C N Robson, G I Shapiro, N J Curtin
Editorial Expression of Concern: Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells. British journal of cancer 131 (5) (2024)
Mark P Ward, Sharon A O'Toole, John J O'Leary
Potential role of the CD39-CD73 ATP-adenosine pathway in platelet mediated dissemination of circulating tumour cells. British journal of cancer 131 (5) (2024)
Rebecca S Kristeleit, Alexandra Leary, Ana Oaknin, Andres Redondo, Angela George, Stephen Chui, Aicha Seiller, Mario Liste-Hermoso, Jenna Willis, Colby S Shemesh, Jim Xiao, Kevin K Lin, Luciana Molinero, Yinghui Guan, Isabelle L Ray-Coquard, Linda R Mileshkin
PARP inhibition with rucaparib alone followed by combination with atezolizumab: Phase Ib COUPLET clinical study in advanced gynaecological and triple-negative breast cancers. British journal of cancer 131 (5) (2024)
Che-Yuan Hsu, Teruki Yanagi, Takuya Maeda, Hiroshi Nishihara, Takeru Funakoshi, Kodai Miyamoto, Ririko Iwamoto, Kenzo Takahashi, Hideyuki Ujiie
Establishment of a trastuzumab-resistant extramammary Paget disease model: loss of PTEN as a potential mechanism. British journal of cancer 131 (5) (2024)
Tiandong Li, Guiying Sun, Hua Ye, Caijuan Song, Yajing Shen, Yifan Cheng, Yuanlin Zou, Zhaoyang Fang, Jianxiang Shi, Keyan Wang, Liping Dai, Peng Wang
ESCCPred: a machine learning model for diagnostic prediction of early esophageal squamous cell carcinoma using autoantibody profiles. British journal of cancer 131 (5) (2024)
Olivia R Grafinger, John J Hayward, Ying Meng, Jennifer Geddes-McAlister, Yan Li, Sara Mar, Minzhi Sheng, Boyang Su, Gobi Thillainadesan, Nir Lipsman, Marc G Coppolino, John F Trant, Katarzyna Joanna Jerzak, Hon Sing Leong
Cancer cell extravasation requires i plectin-mediated delivery of MT1-MMP at invadopodia. British journal of cancer 131 (5) (2024)
Rebecca L O'Leary, Lucien E M Duijm, Liesbeth J Boersma, Maurice J C van der Sangen, Linda de Munck, Jelle Wesseling, Robert-Jan Schipper, Adri C Voogd
Invasive recurrence after breast conserving treatment of ductal carcinoma in situ of the breast in the Netherlands: time trends and the association with tumour grade. British journal of cancer 131 (5) (2024)
Chao An, Ran Wei, Wendao Liu, Yan Fu, Xiaolong Gong, Chengzhi Li, Wang Yao, Mengxuan Zuo, Wang Li, Yansheng Li, Fatian Wu, Kejia Liu, Dong Yan, Pei-Hong Wu, Jianjun Han
Machine learning-based decision support model for selecting intra-arterial therapies for unresectable hepatocellular carcinoma: A national real-world evidence-based study. British journal of cancer 131 (5) (2024)
James A Watkins, Jamie Trotman, John A Tadross, Jennifer Harrington, Helen Hatcher, Gail Horan, Sarah Prewett, Han H Wong, Sarah McDonald, Patrick Tarpey, Thomas Roberts, Jing Su, Marc Tischkowitz, Ruth Armstrong, M Fernanda Amary, Alona Sosinsky
Introduction and impact of routine whole genome sequencing in the diagnosis and management of sarcoma. British journal of cancer 131 (5) (2024)
Isabelle Suvaal, Susanna B Hummel, Jan-Willem M Mens, Charlotte C Tuijnman-Raasveld, Roula Tsonaka, Laura A Velema, Henrike Westerveld, Jeltsje S Cnossen, An Snyers, Ina M Jürgenliemk-Schulz, Ludy C H W Lutgens, Jannet C Beukema, Marie A D Haverkort, Marlies E Nowee, Remi A Nout, Cor D de Kroon, Wilbert B van den Hout, Carien L Creutzberg, Helena C van Doorn, Moniek M Ter Kuile
Efficacy of a nurse-led sexual rehabilitation intervention for women with gynaecological cancers receiving radiotherapy: results of a randomised trial. British journal of cancer 131 (5) (2024)
Hannah L Smith, Elaine Willmore, Lisa Prendergast, Nicola J Curtin
ATR, CHK1 and WEE1 inhibitors cause homologous recombination repair deficiency to induce synthetic lethality with PARP inhibitors. British journal of cancer 131 (5) (2024)
Bing-Biao Lin, Qingqing Huang, Binyuan Yan, Mingcheng Liu, Zhiqian Zhang, Hanqi Lei, Ronghua Huang, Jin-Tang Dong, Pang Jun
An 18-gene signature of recurrence-associated endothelial cells predicts tumor progression and castration resistance in prostate cancer. British journal of cancer 131 (5) (2024)
Andrej Besse, Lenka Sedlarikova, Lorina Buechler, Marianne Kraus, Chieh-Hsiang Yang, Nicol Strakova, Karel Souček, Jiri Navratil, Marek Svoboda, Alana L Welm, Markus Joerger, Christoph Driessen, Lenka Besse
HIV-protease inhibitors potentiate the activity of carfilzomib in triple-negative breast cancer. British journal of cancer 131 (5) (2024)
Karolina Cyll, Erik Skaaheim Haug, Manohar Pradhan, Ljiljana Vlatkovic, Birgitte Carlsen, Sven Löffeler, Wanja Kildal, Karin Skogstad, Frida Hauge Torkelsen, Rolf Anders Syvertsen, Hanne A Askautrud, Knut Liestøl, Andreas Kleppe, Håvard E Danielsen
DNA ploidy and PTEN as biomarkers for predicting aggressive disease in prostate cancer patients under active surveillance. British journal of cancer 131 (5) (2024)
Abdoulaye Karaboué, Pasquale F Innominato, Nicholas I Wreglesworth, Boris Duchemann, René Adam, Francis A Lévi
Why does circadian timing of administration matter for immune checkpoint inhibitors' efficacy? British journal of cancer 131 (5) (2024)